Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Myelodysplastic Syndromes 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia 3Anemia, Refractory, with Excess of Blasts 3Leukemia, Myelomonocytic, Chronic 2Anemia, Refractory 2Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Blast Crisis 1Anemia 1

Interventions

fludarabine phosphate 22Cyclophosphamide 20Busulfan 20Peripheral Blood Stem Cell Transplantation 16Cyclosporine 16Filgrastim 13Antilymphocyte Serum 13Mycophenolic Acid 11Melphalan 11Radiotherapy 10Methotrexate 10Cytarabine 10Methylprednisolone 9Cord Blood Stem Cell Transplantation 9Whole-Body Irradiation 8Tacrolimus 8Etoposide 8Granulocyte Colony-Stimulating Factor 5fludarabine 4Thiotepa 4Sirolimus 4Carboplatin 4Topotecan 3Leucovorin 3lintuzumab 2Vorinostat 2Tretinoin 2Therapeutics 2Immunoenzyme Techniques 2Idarubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blast Crisis × Thalidomide × Classical hematology × Clear all
NCT00053287 2010-06-10

Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS

Case Comprehensive Cancer Center

Phase 2 Completed
42 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡